FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Tadao Akizawa

Research Profile

Procedures

Renal Dialysis

Disorders

Geographic Areas

Japan

Chemicals & Drugs

Concepts & Ideas

Anatomy

Parathyroid Glands

Activities & Behaviors

Physician's Practice Patterns

Co-author Network

Publications

TOP 3
Ikuto Masakane; Michio Mineshima; Yoshiaki Takemoto; Junji Uchino; Hideki Hirakata; Taketoshi Hoshino; Tadaaki Igoshi; Hideki Kawanishi; Tadao Akizawa
2011 JSDT standard on the management of endotoxin retentive filter for dialysis and related therapies.
Masayuki Iyoda; Yoshihiro Kuno; Kei Matsumoto; Takanori Shibata; Yuki Shindo-Hirai; Yukihiro Wada; Tadao Akizawa
Long- and short-term treatment with imatinib attenuates the development of chronic kidney disease in experimental anti-glomerular basement membrane nephritis.
Dick De Zeeuw; Melissa Krauth; Hiddo J Lambers Heerspink; John J McMurray; Colin J Meyer; Hans-Henrik Parving; Pablo E Pergola; Giuseppe Remuzzi; Robert D Toto; Nosratola D Vaziri; Christoph Wanner; David G Warnock; Janet Wittes; Rajiv Agarwal; Tadao Akizawa; Paul Audhya; George L Bakris; Melanie Chin; Glenn M Chertow
Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Tadao Akizawa (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ikuto Masakane; Michio Mineshima; Yoshiaki Takemoto; Junji Uchino; Hideki Hirakata; Taketoshi Hoshino; Tadaaki Igoshi; Hideki Kawanishi; Tadao Akizawa
2011 JSDT standard on the management of endotoxin retentive filter for dialysis and related therapies.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2013;17(2):229-40.
2013: Masayuki Iyoda; Yoshihiro Kuno; Kei Matsumoto; Takanori Shibata; Yuki Shindo-Hirai; Yukihiro Wada; Tadao Akizawa
Long- and short-term treatment with imatinib attenuates the development of chronic kidney disease in experimental anti-glomerular basement membrane nephritis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2013;28(3):576-84.
2013: Dick De Zeeuw; Melissa Krauth; Hiddo J Lambers Heerspink; John J McMurray; Colin J Meyer; Hans-Henrik Parving; Pablo E Pergola; Giuseppe Remuzzi; Robert D Toto; Nosratola D Vaziri; Christoph Wanner; David G Warnock; Janet Wittes; Rajiv Agarwal; Tadao Akizawa; Paul Audhya; George L Bakris; Melanie Chin; Glenn M Chertow
Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON).
American journal of nephrology 2013;37(3):212-22.
2012: Yoshiharu Tsubakihara; Yuzou Watanabe; Takashi Akiba; Fumitake Gejyo; Hideki Hirakata; Yasuhiko Iino; Shinichi Nishi; Akira Saito; Masashi Suzuki; Tadao Akizawa
High target hemoglobin with erythropoiesis-stimulating agents has advantages in the renal function of non-dialysis chronic kidney disease patients.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2012;16(6):529-40.
2012: Hideki Hirakata; Sumio Hirata; Yuji Ikari; Masaaki Inaba; Tohru Inoue; Kunitoshi Iseki; Nobuhiko Joki; Shuzo Kobayashi; Kiyotaka Kugiyama; Yoshitaka Kumada; Masato Nishimura; Kosaku Nitta; Shigeyuki Ozaki; Kazuaki Shimamoto; Tetsuo Shoji; Kaoru Tabei; Tadashi Tomo; Yoshiharu Tsubakihara; Kazuhiko Tsuruya; Hiroyoshi Yokoi; Takashi Akiba; Tadao Akizawa; Hideki Fujii; Shouichi Fujimoto; Hiroki Hase
Japanese Society for Dialysis Therapy guidelines for management of cardiovascular diseases in patients on chronic hemodialysis.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2012;16(5):387-435.
2012: Masafumi Fukagawa; Tadao Akizawa; Shingo Fukuma; Takeshi Hasegawa; Kiyoshi Kurokawa; Yoshihiro Onishi; Takuhiro Yamaguchi; Shunichi Fukuhara
Prescription patterns and mineral metabolism abnormalities in the cinacalcet era: results from the MBD-5D study.
Clinical journal of the American Society of Nephrology : CJASN 2012;7(9):1473-80.
2012: Bruce M Robinson; Rajiv Saran; Francesca Tentori; Lin Tong; Robert A Wolfe; Jinyao Zhang; Tadao Akizawa; Shunichi Fukuhara; David A Goodkin; Roger N Greenwood; Peter G Kerr; Yun Li; Hal Morgenstern; Ronald L Pisoni; Friedrich K Port
Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study.
Kidney international 2012;82(5):570-80.
2012: Aki Kuroki; Tadao Akizawa
[Drug-induced nephrotic syndrome].
Nihon rinsho. Japanese journal of clinical medicine 2012;70 Suppl 6():419-22.
2012: Takashi Akiba; Ryoichi Ando; Takashi Harada; Hideki Hirakata; Kazuhiko Hora; Michio Imawari; Namiki Izumi; Kan Kikuchi; Chifumi Sato; Eiji Tanaka; Tadashi Tomo; Tadao Akizawa
2011 Japanese Society for Dialysis Therapy guidelines for the treatment of hepatitis C virus infection in dialysis patients.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2012;16(4):289-310.
2012: Yumie Aoshima; Eriko Kinugasa; Fumihiko Koiwa; Fumiko Kondo; Chiaki Kumata; Masahide Mizobuchi; Ai Nakazawa; Hiroaki Ogata; Naoko Ono; Tadao Akizawa
Vitamin D receptor activators inhibit vascular smooth muscle cell mineralization induced by phosphate and TNF-α.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012;27(5):1800-6.
2012: Hirokazu Honda; Shiho Kojima; Shinichi Mashiba; Tetsuo Michihata; Kanji Shishido; Keiko Takahashi; Masashi Ueda; Tadao Akizawa
Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients.
Atherosclerosis 2012;220(2):493-501.
2012: Tetsuya Fujikawa; Shunichi Fukuhara; Yumiko Ikeda; Kiyoshi Kurokawa; Takashi Akiba; Tadao Akizawa; Akira Saito
Time-dependent resistance to erythropoiesis-stimulating agent and mortality in hemodialysis patients in the Japan dialysis outcomes and practice patterns study.
Nephron. Clinical practice 2012;122(1-2):24-32.
2012: Makoto Suzuki; Yoshiharu Tsubakihara; Makoto Akaishi; Kazutaka Aonuma; Yoshiyuki Hada; Michiaki Hiroe; Tadao Akizawa
Effects of anemia correction by erythropoiesis-stimulating agents on cardiovascular function in non-dialysis patients with chronic kidney disease.
International heart journal 2012;53(4):238-43.
2012: Shunichi Fukuhara; Satoshi Morita; Tadao Akizawa; Yoshiharu Tsubakihara
Understanding measurements of vitality in patients with chronic kidney disease: connecting a quality-of-life scale to daily activities.
PloS one 2012;7(7):e40455.
2012: Masaaki Inaba; Kiyoshi Kurokawa; Akira Saito; Tetsuo Shoji; Takashi Akiba; Tadao Akizawa; Yasuaki Hayashino; Shunichi Fukuhara
Disappearance of association in diabetic patients on hemodialysis between anemia and mortality risk: the Japan dialysis outcomes and practice pattern study.
Nephron. Clinical practice 2012;120(2):c91-c100.
2012: Hirokazu Honda; Nozomu Hosaka; Tetsuo Michihata; Yumie Aoshima; Yuki Hirai; Tadao Akizawa
Olmesartan medoxomil is associated with decreased plasma AGEs, pentosidine, and N-(epsilon)-carboxymethyl-lysine levels in hemodialysis patients.
Clinical and experimental hypertension (New York, N.Y. : 1993) 2012;34(1):17-23.
2012: Ryuji Suzuki; Hirokazu Honda; Kazuhiko Niikura; Tadao Akizawa
Olmesartan medoxomil treatment is associated with decreased plasma B-type natriuretic peptide levels in patients on hemodialysis.
Clinical and experimental hypertension (New York, N.Y. : 1993) 2012;34(2):125-31.
2011: Masahide Mizobuchi; Ai Nakazawa; Tadao Akizawa
[Bone and calcium update; diagnosis and therapy of metabolic bone disease update. Advances in treatment of CKD-MBD].
Clinical calcium 2011;21(12):159-66.
2011: Minoru Kubota; Satoshi Morita; Masato Yamakawa; Tadao Akizawa; Shunichi Fukuhara; Makoto Hiramatsu; Manabu Iwasaki
Darbepoetin alfa (KRN321) is safe and effective when administered subcutaneously once every 2 or 4 weeks to patients on peritoneal dialysis in Japan.
Clinical and experimental nephrology 2011;15(6):884-92.
2011: Tadao Akizawa; Shunichi Fukuhara; Fumitake Gejyo; Yoshiyuki Hada; Hideki Hirakata; Michiaki Hiroe; Yasuhiko Iino; Manabu Iwasaki; Satoshi Morita; Shinichi Nishi; Akira Saito; Masashi Suzuki; Makoto Suzuki; Yoshiharu Tsubakihara; Yuzou Watanabe; Makoto Akaishi; Takashi Akiba
Positive outcomes of high hemoglobin target in patients with chronic kidney disease not on dialysis: a randomized controlled study.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2011;15(5):431-40.
2011: Tadao Akizawa
[108th Scientific Meeting of the Japanese Society of Internal Medicine: symposium: 3. The interaction between kidney and other organs; What should physicians know about it? (5) Interaction between kidney and bone].
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 2011;100(9):2559-63.
2011: Tadao Akizawa; Masafumi Fukagawa; Shunichi Fukuhara; Takeshi Hasegawa; Ryo Kido; Yoshihiro Onishi; Takuhiro Yamaguchi; Kiyoshi Kurokawa
Decreases in PTH in Japanese hemodialysis patients with secondary hyperparathyroidism: associations with changing practice patterns.
Clinical journal of the American Society of Nephrology : CJASN 2011;6(9):2280-8.
2011: Bernard CANAUD; Brenda Gillespie; Angelo Karaboyas; Ronald L Pisoni; Takashi Akiba; Tadao Akizawa; Juergen Bommer; Francesca Tentori; Lin Tong; Friedrich K Port
Clinical practices and outcomes in elderly hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Clinical journal of the American Society of Nephrology : CJASN 2011;6(7):1651-62.
2011: Masaomi Nangaku; Tadao Akizawa
Diary of a Japanese nephrologist during the present disaster: part II.
Kidney international 2011;80(1):3-5.
2011: Takatoshi Kakuta; Hitoshi Kato; Hirotaka Komaba; Tadao Akizawa
Parathyroid hormone control survey to determine inter-method and inter-lab variations in Japan.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2011;15 Suppl 1():50-5.
2011: Chiaki Kumata; Masahide Mizobuchi; Hiroaki Ogata; Fumihiko Koiwa; Fumiko Kondo; Eriko Kinugasa; Tadao Akizawa
Involvement of matrix metalloproteinase-2 in the development of medial layer vascular calcification in uremic rats.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2011;15 Suppl 1():18-22.
2011: Masafumi Fukagawa; Tadao Akizawa
Recent advances in CKD-MBD research.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2011;15 Suppl 1():1.
2011: Masaomi Nangaku; Tadao Akizawa
Diary of a Japanese nephrologist during the present disaster.
Kidney international 2011;79(10):1037-9.
2011: Shunichi Fukuhara; Tadao Akizawa; Masafumi Fukagawa; Yoshihiro Onishi; Takuhiro Yamaguchi; Takeshi Hasegawa; Kiyoshi Kurokawa
Mineral and bone disorders outcomes study for Japanese chronic kidney disease stage 5D patients: rationale and study design.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2011;15(2):169-75.
2011: Tadao Akizawa; Hirofumi Makino; Seiichi Matsuo; Tsuyoshi Watanabe; Enyu Imai; Kosaku Nitta; Yasuo Ohashi; Akira Hishida
Management of anemia in chronic kidney disease patients: baseline findings from Chronic Kidney Disease Japan Cohort Study.
Clinical and experimental nephrology 2011;15(2):248-57.
2011: Yoshihiro Kuno; Masayuki Iyoda; Takanori Shibata; Yuki Hirai; Tadao Akizawa
Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in non-insulin-dependent Otsuka Long-Evans Tokushima Fatty rats.
British journal of pharmacology 2011;162(6):1389-400.
2011: David A Goodkin; Douglas S Fuller; Bruce M Robinson; Christian Combe; Richard Fluck; David Mendelssohn; Tadao Akizawa; Ronald L Pisoni; Friedrich K Port
Naturally occurring higher hemoglobin concentration does not increase mortality among hemodialysis patients.
Journal of the American Society of Nephrology : JASN 2011;22(2):358-65.
2011: Takeshi Hasegawa; Jennifer L Bragg-Gresham; Ronald L Pisoni; Bruce M Robinson; Shunichi Fukuhara; Takashi Akiba; Akira Saito; Kiyoshi Kurokawa; Tadao Akizawa
Changes in anemia management and hemoglobin levels following revision of a bundling policy to incorporate recombinant human erythropoietin.
Kidney international 2011;79(3):340-6.
2011: Takaya Abe; Tomoaki Fujioka; Karen Kato; Tadao Akizawa
The blood compatibilities of blood purification membranes and other materials developed in Japan.
International journal of biomaterials 2011;2011():375390.
2011: Susumu Uda; Masahide Mizobuchi; Tadao Akizawa
Biocompatible characteristics of high-performance membranes.
Contributions to nephrology 2011;173():23-9.
2011: Masahide Mizobuchi; Ai Nakazawa; Hiroaki Ogata; Nozomu Hosaka; Eriko Kinugasa; Fumihiko Koiwa; Fumiko Kondo; Chiaki Kumata; Tadao Akizawa
Effects of calcimimetic combined with an angiotensin-converting enzyme inhibitor on uremic cardiomyopathy progression.
American journal of nephrology 2011;34(3):256-67.
2011: Masafumi Fukagawa; Hirotaka Komaba; Yoshihiro Onishi; Shunichi Fukuhara; Tadao Akizawa; Kiyoshi Kurokawa
Mineral metabolism management in hemodialysis patients with secondary hyperparathyroidism in Japan: baseline data from the MBD-5D.
American journal of nephrology 2011;33(5):427-37.
2011: Hiroki Suzuki; Keiko Takahashi; Hirokazu Honda; Noriyuki Kato; Tetsuo Michihata; Kanji Shishido; Tadao Akizawa
Assessment of inflow of endotoxin and its fragments in patients on maintenance hemodialysis.
Blood purification 2011;31(4):268-75.
2011: Aurélie Untas; Jyothi Thumma; Nicole Rascle; Hugh Rayner; Donna Mapes; Antonio A Lopes; Shunichi Fukuhara; Tadao Akizawa; Hal Morgenstern; Bruce M Robinson; Ronald L Pisoni; Christian Combe
The associations of social support and other psychosocial factors with mortality and quality of life in the dialysis outcomes and practice patterns study.
Clinical journal of the American Society of Nephrology : CJASN 2011;6(1):142-52.
2010: Tadao Akizawa
Japanese Society for Dialysis Therapy: presidential address upon reappointment.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2010;14(6):487-8.
2010: Hiroaki Ogata; Chiaki Kumata-Maeta; Kanji Shishido; Masahide Mizobuchi; Masahiro Yamamoto; Fumihiko Koiwa; Eriko Kinugasa; Tadao Akizawa
Detection of peripheral artery disease by duplex ultrasonography among hemodialysis patients.
Clinical journal of the American Society of Nephrology : CJASN 2010;5(12):2199-206.
2010: Enyu Imai; Seiichi Matsuo; Hirofumi Makino; Tsuyoshi Watanabe; Tadao Akizawa; Kosaku Nitta; Satoshi Iimuro; Yasuo Ohashi; Akira Hishida
Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function.
Clinical and experimental nephrology 2010;14(6):558-70.
2010: Yasuaki Hayashino; Shunichi Fukuhara; Tadao Akizawa; Yasushi Asano; Takafumi Wakita; Yoshihiro Onishi; Kiyoshi Kurokawa
Cost-effectiveness of administering oral adsorbent AST-120 to patients with diabetes and advance-stage chronic kidney disease.
Diabetes research and clinical practice 2010;90(2):154-9.
2010: Kazuhiro Shiizaki; Ikuji Hatamura; Masafumi Fukagawa; Eiko Nakazawa; Fumie Saji; Yuko Watanabe; Tadao Akizawa; Eiji Kusano
Development of a technique for introduction of an expressed complementary deoxyribonucleic acid into parathyroid cells by direct injection.
Endocrinology 2010;151(8):4031-8.
2010: Masahide Mizobuchi; Yumie Aoshima; Tadao Akizawa
[CKD-MBD (chronic kidney disease-mineral and bone disorder). CKD-MBD: chronic kidney disease-mineral and bone disorder].
Clinical calcium 2010;20(7):995-1003.
2010: Antonio Alberto Lopes; Jennifer Bragg-Gresham; Stacey J Elder; Nancy Ginsberg; David A Goodkin; Trinh B Pifer; Norbert Lameire; Mark R Marshall; Yasushi Asano; Tadao Akizawa; Ronald L Pisoni; Eric W Young; Friedrich K Port
Independent and joint associations of nutritional status indicators with mortality risk among chronic hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2010;20(4):224-34.
2010: Maho Omori; Makoto Watanabe; Kei Matsumoto; Hirokazu Honda; Hiroaki Hattori; Tadao Akizawa
Impact of serum apolipoprotein A-IV as a marker of cardiovascular disease in maintenance hemodialysis patients.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2010;14(3):341-8.
2010: Eijin Ashikaga; Hirokazu Honda; Hiroki Suzuki; Nozomu Hosaka; Yuki Hirai; Daisuke Sanada; Mari Nakamura; Hisako Nagai; Kei Matsumoto; Noriyuki Kato; Masanori Mukai; Makoto Watanabe; Keiko Takahashi; Kanji Shishido; Tadao Akizawa
Impact of fibroblast growth factor 23 on lipids and atherosclerosis in hemodialysis patients.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2010;14(3):315-22.
2010: Yoshiharu Tsubakihara; Shinichi Nishi; Takashi Akiba; Hideki Hirakata; Kunitoshi Iseki; Minoru Kubota; Satoru Kuriyama; Yasuhiro Komatsu; Masashi Suzuki; Shigeru Nakai; Motoshi Hattori; Tetsuya Babazono; Makoto Hiramatsu; Hiroyasu Yamamoto; Masami Bessho; Tadao Akizawa
2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2010;14(3):240-75.
2010: Hirokazu Honda; Masashi Ueda; Shiho Kojima; Shinichi Mashiba; Hiroki Suzuki; Nozomu Hosaka; Yuki Hirai; Mari Nakamura; Hisako Nagai; Noriyuki Kato; Masanori Mukai; Makoto Watanabe; Keiko Takahashi; Kanji Shishido; Tadao Akizawa
Oxidized high-density lipoprotein is associated with protein-energy wasting in maintenance hemodialysis patients.
Clinical journal of the American Society of Nephrology : CJASN 2010;5(6):1021-8.
2010: Kunihiro Yamagata; Hirofumi Makino; Tadao Akizawa; Kunitoshi Iseki; Sadayoshi Itoh; Kenjiro Kimura; Daisuke Koya; Ichiei Narita; Tetsuya Mitarai; Masanobu Miyazaki; Yoshiharu Tsubakihara; Tsuyoshi Watanabe; Takashi Wada; Osamu Sakai
Design and methods of a strategic outcome study for chronic kidney disease: Frontier of Renal Outcome Modifications in Japan.
Clinical and experimental nephrology 2010;14(2):144-51.
2010: Masayuki Iyoda; Takanori Shibata; Mio Kawaguchi; Nobuyuki Hizawa; Toshimitsu Yamaoka; Fumio Kokubu; Tadao Akizawa
IL-17A and IL-17F stimulate chemokines via MAPK pathways (ERK1/2 and p38 but not JNK) in mouse cultured mesangial cells: synergy with TNF-alpha and IL-1beta.
American journal of physiology. Renal physiology 2010;298(3):F779-87.
2010: Hideki Hirakata; Yoshiharu Tsubakihara; Fumitake Gejyo; Shinichi Nishi; Yasuhiko Iino; Yuzou Watanabe; Masashi Suzuki; Akira Saito; Takashi Akiba; Daijo Inaguma; Shunichi Fukuhara; Satoshi Morita; Michiaki Hiroe; Yoshiyuki Hada; Makoto Suzuki; Makoto Akaishi; Kazutaka Aonuma; Tadao Akizawa
Maintaining high hemoglobin levels improved the left ventricular mass index and quality of life scores in pre-dialysis Japanese chronic kidney disease patients.
Clinical and experimental nephrology 2010;14(1):28-35.
2010: Hiroo Ichikawa; Masanori Mukai; Soutaro Hieda; Yuki Kamiya; Tadao Akizawa; Mitsuru Kawamura
Involvement of the basilar artery in diabetes mellitus: an MRI study of brainstem infarctions.
European neurology 2010;64(4):230-5.
2010: Yoshihiro Kuno; Masayuki Iyoda; Yumie Aoshima; Nozomu Hosaka; Daisuke Sanada; Yuki Hirai; Takanori Shibata; Tadao Akizawa
A case of tuberculous peritonitis in a hemodialysis patient with high serum soluble interleukin-2 receptor and CA-125 levels.
Internal medicine (Tokyo, Japan) 2010;49(16):1783-6.
2010: Chiaki Kumata; Masahide Mizobuchi; Hiroaki Ogata; Fumihiko Koiwa; Ai Nakazawa; Fumiko Kondo; Yoshiyuki Kadokura; Eriko Kinugasa; Tadao Akizawa
Involvement of alpha-klotho and fibroblast growth factor receptor in the development of secondary hyperparathyroidism.
American journal of nephrology 2010;31(3):230-8.
2009: Nozomu Hosaka; Masahide Mizobuchi; Hiroaki Ogata; Chiaki Kumata; Fumiko Kondo; Fumihiko Koiwa; Eriko Kinugasa; Tadao Akizawa
Elastin degradation accelerates phosphate-induced mineralization of vascular smooth muscle cells.
Calcified tissue international 2009;85(6):523-9.
2009: Hiroo Ichikawa; Nobuyoshi Takahashi; Masanori Mukai; Hirotaka Katoh; Tadao Akizawa; Mitsuru Kawamura
Intracranial dilative arteriopathy is associated with chronic kidney disease and small vessel diseases in the elderly.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2009;18(6):435-42.
2009: Kazuhiro Shiizaki; Ikuji Hatamura; Ikuo Imazeki; Yoshiyuki Moriguchi; Toshifumi Sakaguchi; Fumie Saji; Eiko Nakazawa; Shigeaki Kato; Tadao Akizawa; Eiji Kusano
Improvement of impaired calcium and skeletal homeostasis in vitamin D receptor knockout mice by a high dose of calcitriol and maxacalcitol.
Bone 2009;45(5):964-71.
2009: Yasuaki Hayashino; Shirou Fukuhara; Takashi Akiba; Tadao Akizawa; Y Asano; S Saito; Kiyoshi Kurokawa
Low health-related quality of life is associated with all-cause mortality in patients with diabetes on haemodialysis: the Japan Dialysis Outcomes and Practice Pattern Study.
Diabetic medicine : a journal of the British Diabetic Association 2009;26(9):921-7.
2009: Tadao Akizawa; Yasushi Asano; Satoshi Morita; Takafumi Wakita; Yoshihiro Onishi; Shunichi Fukuhara; Fumitake Gejyo; Seiichi Matsuo; Noriaki Yorioka; Kiyoshi Kurokawa
Effect of a carbonaceous oral adsorbent on the progression of CKD: a multicenter, randomized, controlled trial.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2009;54(3):459-67.
2009: Yoshie Yamamoto; Yasuaki Hayashino; Shin Yamazaki; Takashi Akiba; Tadao Akizawa; Y Asano; A Saito; Kiyoshi Kurokawa; Yoshiki Miyachi; S Fukuhara
Depressive symptoms predict the future risk of severe pruritus in haemodialysis patients: Japan Dialysis Outcomes and Practice Patterns Study.
The British journal of dermatology 2009;161(2):384-9.
2009: Yosuke Yamamoto; Yasuaki Hayashino; Takashi Akiba; Tadao Akizawa; Yasushi Asano; Akira Saito; Kiyoshi Kurokawa; Shunichi Fukuhara
Depressive symptoms predict the subsequent risk of bodily pain in dialysis patients: Japan Dialysis Outcomes and Practice Patterns Study.
Pain medicine (Malden, Mass.) 2009;10(5):883-9.
2009: Masahide Mizobuchi; Hiroaki Ogata; Fumihiko Koiwa; Eriko Kinugasa; Tadao Akizawa
Vitamin D and vascular calcification in chronic kidney disease.
Bone 2009;45 Suppl 1():S26-9.
2009: Masayuki Iyoda; Takanori Shibata; Mio Kawaguchi; Toshimitsu Yamaoka; Tadao Akizawa
Preventive and therapeutic effects of imatinib in Wistar-Kyoto rats with anti-glomerular basement membrane glomerulonephritis.
Kidney international 2009;75(10):1060-70.
2009: Hideki Kawanishi; Takashi Akiba; Ikuto Masakane; Tadashi Tomo; Michio Mineshima; Tadayuki Kawasaki; Hideki Hirakata; Tadao Akizawa
Standard on microbiological management of fluids for hemodialysis and related therapies by the Japanese Society for Dialysis Therapy 2008.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2009;13(2):161-6.
2009: Makoto Watanabe; Hiroki Suzuki; Tadao Akizawa
[Chronic kidney disease (CKD) and bone. CKD-MBD managements and view in the future].
Clinical calcium 2009;19(4):559-65.
2009: Takeshi Hasegawa; Jennifer Bragg-Gresham; Shin Yamazaki; Shunichi Fukuhara; Tadao Akizawa; Werner Kleophas; Roger Greenwood; Ronald L Pisoni
Greater first-year survival on hemodialysis in facilities in which patients are provided earlier and more frequent pre-nephrology visits.
Clinical journal of the American Society of Nephrology : CJASN 2009;4(3):595-602.
2009: Masahide Mizobuchi; Daisuke Sanada; Tadao Akizawa
[Novel phosphate binders under development].
Clinical calcium 2009;19(2):237-41.
2009: Kazuki Kawakami; Hirotaka Takama; Daisuke Nakashima; Hideji Tanaka; Eiji Uchida; Tadao Akizawa
Population pharmacokinetics of darbepoetin alpha in peritoneal dialysis and non-dialysis patients with chronic kidney disease after single subcutaneous administration.
European journal of clinical pharmacology 2009;65(2):169-78.
2009: Eijin Ashikaga; Masayuki Iyoda; H Suzuki; Hisako Nagai; Takanori Shibata; Tadao Akizawa
[Case of microscopic polyangiitis presenting initially as prostatic vasculitis].
Nihon Jinzo Gakkai shi 2009;51(8):1075-9.
2009: Hirokazu Honda; Tadao Akizawa
[Choice of maintenance dialysis therapy in patients with CKD stage 5D].
Nihon Jinzo Gakkai shi 2009;51(7):857-9.
2009: Yoko Yokoyama; Shin Yamazaki; Takeshi Hasegawa; Takafumi Wakita; Yasuaki Hayashino; Misa Takegami; Takashi Akiba; Tadao Akizawa; Yasushi Asano; Akira Saito; Kiyoshi Kurokawa; Shunichi Fukuhara
Impact of early referral to nephrologist on mental health among hemodialysis patients: a Dialysis Outcomes and Practice Patterns Study (DOPPS).
Nephron. Clinical practice 2009;113(3):c191-7.
2009: Kazushi Nakao; Hirofumi Makino; Satoshi Morita; Yoshimitsu Takahashi; Tadao Akizawa; Akira Saito; Yasushi Asano; Kiyoshi Kurokawa; Shunichi Fukuhara; Takashi Akiba
Beta-blocker prescription and outcomes in hemodialysis patients from the Japan Dialysis Outcomes and Practice Patterns Study.
Nephron. Clinical practice 2009;113(3):c132-9.
2009: Hirokazu Honda; Hiroki Suzuki; Nozomu Hosaka; Yuki Hirai; Daisuke Sanada; Mari Nakamura; Hisako Nagai; Eijin Ashikaga; Kei Matsumoto; Masanori Mukai; Makoto Watanabe; Tadao Akizawa
Ultrapure dialysate influences serum myeloperoxidase levels and lipid metabolism.
Blood purification 2009;28(1):29-39.
2009: Hirokazu Honda; Masashi Ueda; Shiho Kojima; Shinichi Mashiba; Yuki Hirai; Nozomu Hosaka; Hiroki Suzuki; Masanori Mukai; Makoto Watanabe; Keiko Takahashi; Kanji Shishido; Tadao Akizawa
Assessment of myeloperoxidase and oxidative alpha1-antitrypsin in patients on hemodialysis.
Clinical journal of the American Society of Nephrology : CJASN 2009;4(1):142-51.
2009: Takashi Shigematsu; Tadao Akizawa; Eiji Uchida; Yusuke Tsukamoto; Manabu Iwasaki; Shouzo Koshikawa
Long-term cinacalcet HCl treatment improved bone metabolism in Japanese hemodialysis patients with secondary hyperparathyroidism.
American journal of nephrology 2009;29(3):230-6.
2008: Kozo Kitazawa; Kensuke Joh; Tadao Akizawa
A case of lupus nephritis coexisting with podocytic infolding associated with Takayasu's arteritis.
Clinical and experimental nephrology 2008;12(6):462-6.
2008: Hiroo Ichikawa; Nobuyoshi Takahashi; Masanori Mukai; Tadao Akizawa; Mitsuru Kawamura
Asymptomatic large T2 high-signal pontine lesions that are different from ischemic rarefaction.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2008;17(6):394-400.
2008: Tadao Akizawa; Ronald L Pisoni; Takashi Akiba; Akira Saito; Shunichi Fukuhara; Yasushi Asano; Takeshi Hasegawa; Friedrich K Port; Kiyoshi Kurokawa
Japanese haemodialysis anaemia management practices and outcomes (1999-2006): results from the DOPPS.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(11):3643-53.
2008: Aiji Yajima; Tadao Akizawa; Yusuke Tsukamoto; Satoshi Kurihara; Akemi Ito
Impact of cinacalcet hydrochloride on bone histology in patients with secondary hyperparathyroidism.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2008;12 Suppl 1():S38-43.
2008: Tadao Akizawa; Shozo Koshikawa
Clinical study of cinacalcet in Japan.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2008;12 Suppl 1():S13-5.
2008: Tadao Akizawa
19th Annual Meeting of the Japanese Society for Kidney Bone Disease.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2008;12 Suppl 1():S1.
2008: Jean Ethier; David C Mendelssohn; Stacey J Elder; Takeshi Hasegawa; Tadao Akizawa; Takashi Akiba; Bernard CANAUD; Ronald L Pisoni
Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(10):3219-26.
2008: Yuki Hirai; Masayuki Iyoda; Takanori Shibata; Eijin Ashikaga; Nozomu Hosaka; Hiroki Suzuki; Hisako Nagai; Masanori Mukai; Hirokazu Honda; Aki Kuroki; Kozo Kitazawa; Tadao Akizawa
Lupus nephritis associated with positive MPO-ANCA in a patient with underlying autoimmune hemolytic anemia.
Clinical and experimental nephrology 2008;12(5):393-7.
2008: Aki Kuroki; Tadao Akizawa
[Management of chronic kidney disease--preventing the progression of renal disease].
Nihon rinsho. Japanese journal of clinical medicine 2008;66(9):1735-40.
2008: Takeshi Hasegawa; Stacey J Elder; Jennifer Bragg-Gresham; Ronald L Pisoni; Shin Yamazaki; Tadao Akizawa; Michel Jadoul; Rayner C Hugh; Friedrich K Port; Shunichi Fukuhara
Consistent aspirin use associated with improved arteriovenous fistula survival among incident hemodialysis patients in the dialysis outcomes and practice patterns study.
Clinical journal of the American Society of Nephrology : CJASN 2008;3(5):1373-8.
2008: Francesca Tentori; Margaret J Blayney; Justin M Albert; Brenda W Gillespie; Peter G Kerr; Jürgen Bommer; Eric W Young; Tadao Akizawa; Takashi Akiba; Ronald L Pisoni; Bruce M Robinson; Friedrich K Port
Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
American journal of kidney diseases : the official journal of the National Kidney Foundation 2008;52(3):519-30.
2008: Yukihiro Wada; Toshiaki Kunimura; Shun Sato; Tomokazu Hisayuki; Masashi Sato; Hiromi Imataka; Norimasa Yamashita; Tadao Akizawa; Toshio Moroboshi
Proliferating potential and apoptosis in the development of secondary hyperparathyroidism: a study based on Ki-67 immunohistochemical staining and the terminal dUTP nick-end labeling assay.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2008;12(4):319-28.
2008: Hiroaki Ogata; Yukihiro Wada; Tadao Akizawa
[Role of kidney in calcium homeostasis and premature aging].
Clinical calcium 2008;18(7):942-6.
2008: Enyu Imai; Seiichi Matsuo; Hirofumi Makino; Tsuyoshi Watanabe; Tadao Akizawa; Kosaku Nitta; Satoshi Iimuro; Yasuo Ohashi; Akira Hishida
Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods.
Hypertension research : official journal of the Japanese Society of Hypertension 2008;31(6):1101-7.
2008: Kazuhiro Shiizaki; Ikuji Hatamura; Eiko Nakazawa; Manabu Ogura; Takahiro Masuda; Tadao Akizawa; Eiji Kusano
Molecular and morphological approach of uremia-induced hyperplastic parathyroid gland following direct maxacalcitol injection.
Medical molecular morphology 2008;41(2):76-82.
2008: Masayuki Iyoda; Hiroki Suzuki; Eijin Ashikaga; Hisako Nagai; Aki Kuroki; Takanori Shibata; Kozo Kitazawa; Tadao Akizawa
Elderly onset systemic lupus erythematosus (SLE) presenting with disseminated intravascular coagulation (DIC).
Clinical rheumatology 2008;27 Suppl 1():S15-8.
2008: Kazuhiro Shiizaki; Ikuji Hatamura; Shigeo Negi; Toshifumi Sakaguchi; Fumie Saji; Ikuo Imazeki; Eiji Kusano; Takashi Shigematsu; Tadao Akizawa
Highly concentrated calcitriol and its analogues induce apoptosis of parathyroid cells and regression of the hyperplastic gland--study in rats.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(5):1529-36.
2008: Takashi Akiba; Tadao Akizawa; Yusuke Tsukamoto; Eiji Uchida; Manabu Iwasaki; Shozo Koshikawa
Dose determination of cinacalcet hydrochloride in Japanese hemodialysis patients with secondary hyperparathyroidism.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2008;12(2):117-25.
2008: Stacey J Elder; Ronald L Pisoni; Tadao Akizawa; Rachel Fissell; Vittorio E Andreucci; Shunichi Fukuhara; Kiyoshi Kurokawa; Hugh C Rayner; Anna L Furniss; Friedrich K Port; Rajiv Saran
Sleep quality predicts quality of life and mortality risk in haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(3):998-1004.
2008: Shunichi Fukuhara; Tadao Akizawa; Satoshi Morita; Shozo Koshikawa
Quality of life improvements in dialysis patients receiving darbepoetin alfa.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2008;12(1):72-7.
2008: Makoto Hiramatsu; Minoru Kubota; Manabu Iwasaki; Tadao Akizawa; Shozo Koshikawa
Darbepoetin alfa (KRN321) administered intravenously once monthly maintains hemoglobin levels in peritoneal dialysis patients.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2008;12(1):19-27.
2008: Aki Kuroki; J Ito; A Yokochi; N Kato; Tetsuzo Sugisaki; H Sueki; Tadao Akizawa
Diagnosing Alport syndrome using electron microscopy of the skin.
Kidney international 2008;73(3):364-5.
2008: Hitoshi Yokoyama; Takehiko Kawaguchi; Takashi Wada; Yoshinori Takahashi; Takahiro Higashi; Shin Yamazaki; Shunichi Fukuhara; Takashi Akiba; Tadao Akizawa; Yasushi Asano; Kiyoshi Kurokawa; Akira Saito
Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
Nephron. Clinical practice 2008;109(2):c100-8.
2008: Mutsuki Makino; Hirokazu Honda; Fumito Miyoshi; Yoshio Ban; Takashi Katagiri; Taka-Aki Matsuyama; Hidekazu Ota; Osamu Yoshitake; Mitsuo Kusano; Takanori Shibata; Tadao Akizawa
A fulminant case of renal vein thrombosis in a patient with autoimmune disorder and membranous nephropathy.
Internal medicine (Tokyo, Japan) 2008;47(10):969-73.
2008: Takeshi Hasegawa; Yoshimi Suzukamo; Tadao Akizawa; Shunichi Fukuhara
[Validation of the Japanese SF-36 v2 acute form in patients with chronic kidney disease].
Nihon Jinzo Gakkai shi 2008;50(1):42-50.
2008: Masahide Mizobuchi; Tadao Akizawa
[Basic and clinical aspects of calcimimetics. The pathogesis and treatment of secondary hyperparathyroidism].
Clinical calcium 2008;18(1):13-9.
2008: Kazuhiro Shiizaki; Masafumi Fukagawa; Qunsheng Yuan; Ikuji Hatamura; Tomoko Nii-Kono; Fumie Saji; Takashi Shigematsu; Tadao Akizawa
Direct injection of calcitriol or its analog improves abnormal gene expression in the hyperplastic parathyroid gland in uremia.
American journal of nephrology 2008;28(1):59-66.
2008: Masafumi Fukagawa; Shigeru Yumita; Tadao Akizawa; Eiji Uchida; Yusuke Tsukamoto; Manabu Iwasaki; Shozo Koshikawa
Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(1):328-35.
2007: Hiroaki Ogata; Fumihiko Koiwa; Eriko Kinugasa; Tadao Akizawa
CKD-MBD: impact on management of kidney disease.
Clinical and experimental nephrology 2007;11(4):261-8.
2007: Aki Kuroki; Tadao Akizawa; Shozo Koshikawa
[Drug-induced nephrotic syndrome].
Nihon rinsho. Japanese journal of clinical medicine 2007;65 Suppl 8():563-6.
2007: Masahide Mizobuchi; Hiroaki Ogata; Ikuji Hatamura; Fumie Saji; Fumihiko Koiwa; Eriko Kinugasa; Shozo Koshikawa; Tadao Akizawa
Activation of calcium-sensing receptor accelerates apoptosis in hyperplastic parathyroid cells.
Biochemical and biophysical research communications 2007;362(1):11-6.
2007: Jean Ethier; Jennifer Bragg-Gresham; Luis Piera; Tadao Akizawa; Yasushi Asano; Nancy Mason; Brenda W Gillespie; Eric W Young
Aspirin prescription and outcomes in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
American journal of kidney diseases : the official journal of the National Kidney Foundation 2007;50(4):602-11.
2007: Hironori Nakamura; Masanori Mukai; Hirokazu Honda; Tadao Akizawa
Thrombotic thrombocytopenic purpura-like thrombocytopenia closely related to uremia: report of two cases.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2007;11(5):382-6.
2007: Shunichi Fukuhara; Chikao Yamazaki; Yasuaki Hayashino; Takahiro Higashi; Margaret A Eichleay; Takashi Akiba; Tadao Akizawa; Akira Saito; Friedrich K Port; Kiyoshi Kurokawa
The organization and financing of end-stage renal disease treatment in Japan.
International journal of health care finance and economics 2007;7(2-3):217-31.
2007: Xiang-Ming Liang; Haruhisa Otani; Qin Zhou; Yoshinori Tone; Ryoichi Fujii; Masatoshi Mune; Susumu Yukawa; Tadao Akizawa
Renal protective effects of pitavastatin on spontaneously hypercholesterolaemic Imai Rats.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(8):2156-64.
2007: Naoki Kimata; Justin M Albert; Takashi Akiba; Shin Yamazaki; Takehiko Kawaguchi; Yoshindo Kawaguchi; Shunichi Fukuhara; Tadao Akizawa; Akira Saito; Yasushi Asano; Kiyoshi Kurokawa; Ronald L Pisoni; Friedrich K Port
Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: the Japan dialysis outcomes and practice patterns study.
Hemodialysis international. International Symposium on Home Hemodialysis 2007;11(3):340-8.
2007: Masahide Mizobuchi; Jeremiah Morrissey; Jane L Finch; Daniel R Martin; Helen Liapis; Tadao Akizawa; Eduardo Slatopolsky
Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.
Journal of the American Society of Nephrology : JASN 2007;18(6):1796-806.
2007: Tadao Akizawa; Shozo Koshikawa; Manabu Iwasaki
Darbepoetin alfa effectively maintains hemoglobin concentrations at extended dose intervals relative to intravenous rHuEPO in Japanese dialysis patients.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2007;11(3):220-6.
2007: Yasuaki Hayashino; S Fukuhara; Takashi Akiba; Tadao Akizawa; Y Asano; A Saito; Jennifer Bragg-Gresham; S P B Ramirez; Friedrich K Port; K Kurokawa
Diabetes, glycaemic control and mortality risk in patients on haemodialysis: the Japan Dialysis Outcomes and Practice Pattern Study.
Diabetologia 2007;50(6):1170-7.
2007: Motoko Tanaka; Shin Yamazaki; Yasuaki Hayashino; Shunichi Fukuhara; Takashi Akiba; Akira Saito; Yasushi Asano; Friedrich K Port; Kiyoshi Kurokawa; Tadao Akizawa
Hypercalcaemia is associated with poor mental health in haemodialysis patients: results from Japan DOPPS.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(6):1658-64.
2007: Hirokazu Honda; Hisako Nagai; Tadao Akizawa
[Chronic kidney diseases and other diseases. 2. Kidney failure].
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 2007;96(5):894-8.
2007: Hirokazu Honda; Nozomu Hosaka; Tadao Akizawa
[Kidney as a regulating organ for calcium and phosphate homeostasis].
Clinical calcium 2007;17(5):654-8.
2007: Antonio Alberto Lopes; Jennifer Bragg-Gresham; David A Goodkin; Shunichi Fukuhara; Donna L Mapes; Eric W Young; Brenda W Gillespie; Tadao Akizawa; Roger N Greenwood; Vittorio E Andreucci; Takashi Akiba; Philip J Held; Friedrich K Port
Factors associated with health-related quality of life among hemodialysis patients in the DOPPS.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2007;16(4):545-57.
2007: Kazuhiro Shiizaki; Naohiko Hayakawa; Ikuo Imazeki; Ikuji Hatamura; Tadashi Okada; Shigeo Negi; Toshifumi Sakaguchi; Takashi Shigematsu; Tadao Akizawa
Binding of highly concentrated maxacalcitol to the nuclear vitamin D receptors of parathyroid cells.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(4):1078-86.
2007: Hirotaka Takama; Hideji Tanaka; Daisuke Nakashima; Hiroyasu Ogata; Eiji Uchida; Tadao Akizawa; Shozo Koshikawa
Population pharmacokinetics of darbepoetin alfa in haemodialysis and peritoneal dialysis patients after intravenous administration.
British journal of clinical pharmacology 2007;63(3):300-9.
2007: Masafumi Fukagawa; Tadao Akizawa
[Role of the kidney in mineral metabolism].
Nihon Jinzo Gakkai shi 2007;49(4):404-5.
2007: Xiang-Ming Liang; Haruhisa Otani; Qin Zhou; Yoshinori Tone; Ryoichi Fujii; Masatoshi Mune; Susumu Yukawa; Tadao Akizawa
Various dietary protein intakes and progression of renal failure in spontaneously hypercholesterolemic Imai rats.
Nephron. Experimental nephrology 2007;105(4):e98-107.
2007: Shunichi Fukuhara; Shin Yamazaki; Fumiaki Marumo; Takashi Akiba; Tadao Akizawa; Satoru Fujimi; Shigekazu Haruki; Yoshindo Kawaguchi; Hiroshi Nihei; Takao Shoji; Teiryou Maeda
Health-related quality of life of predialysis patients with chronic renal failure.
Nephron. Clinical practice 2007;105(1):c1-8.
2006: Ronald L Pisoni; Björn Wikström; Stacey J Elder; Tadao Akizawa; Yashushi Asano; Marcia L Keen; Rajiv Saran; David C Mendelssohn; Eric W Young; Friedrich K Port
Pruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(12):3495-505.
2006: Shunichi Fukuhara; J Green; J Albert; H Mihara; R Pisoni; S Yamazaki; Takashi Akiba; Tadao Akizawa; Y Asano; A Saito; Friedrich K Port; P Held; Kiyoshi Kurokawa
Symptoms of depression, prescription of benzodiazepines, and the risk of death in hemodialysis patients in Japan.
Kidney international 2006;70(10):1866-72.
2006: Michel Jadoul; Justin M Albert; Takashi Akiba; Tadao Akizawa; Lenore Arab; Jennifer Bragg-Gresham; Nancy A Mason; K-G Prutz; Eric W Young; Ronald L Pisoni
Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study.
Kidney international 2006;70(7):1358-66.
2006: Kazuhiro Shiizaki; Ikuji Hatamura; Shigeo Negi; Toshifumi Sakaguchi; Fumie Saji; K Kunimoto; M Okamoto; Ikuo Imazeki; Yasuteru Muragaki; Tadao Akizawa
Direct maxacalcitol injection into hyperplastic parathyroids improves skeletal changes in secondary hyperparathyroidism.
Kidney international 2006;70(3):486-95.
2006: Hirokazu Honda; Daisuke Sanada; Tadao Akizawa
[Vitamin D metabolism and chronic kidney disease].
Clinical calcium 2006;16(7):1143-46.
2006: Kazuhiro Shiizaki; Shigeo Negi; Ikuji Hatamura; K Tatsuta; M Shibata; S Shimada; Toshifumi Sakaguchi; Tadao Akizawa
Direct injection of calcitriol or its analog into hyperplastic parathyroid glands induces apoptosis of parathyroid cells.
Kidney international. Supplement 2006;(102):S12-5.
2006: Tadao Akizawa
New reimbursement for dialysis in Japan.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2006;10(3):207-8.
2006: Masahide Mizobuchi; Hiroaki Ogata; Ikuji Hatamura; Fumihiko Koiwa; Fumie Saji; Kazuhiro Shiizaki; Shigeo Negi; Eriko Kinugasa; Akira Ooshima; Shozo Koshikawa; Tadao Akizawa
Up-regulation of Cbfa1 and Pit-1 in calcified artery of uraemic rats with severe hyperphosphataemia and secondary hyperparathyroidism.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(4):911-6.
2006: Tadao Akizawa
Does sevelamer have greater skeletal benefit than calcium carbonate in children with secondary hyperparathyroidism?
Nature clinical practice. Nephrology 2006;2(3):130-1.
2006: Satoshi Morita; Shunichi Fukuhara; Tadao Akizawa; Yasushi Asano; Shozo Koshikawa; Keizo Koide; Kiyoshi Kurokawa
Prognostic factors for a composite end-point of renal outcomes in patients with chronic kidney disease.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2006;10(1):72-7.
2006: Toshio Naka; Masahiro Shinozaki; Tadao Akizawa; Yukihiro Shima; Hideki Takaesu; Hideki Nasu
The effect of continuous veno-venous hemofiltration or direct hemoperfusion with polymyxin B-immobilized fiber on neutrophil respiratory oxidative burst in patients with sepsis and septic shock.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2006;10(1):7-11.
2006: Shigeo Negi; Tadao Akizawa
[Treatment of nephrogenic anemia].
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 2006;95(1):140-7.
2006: Tadao Akizawa
[Current strategy for ESRD in Japan].
Nihon Jinzo Gakkai shi 2006;48(8):715-8.
2006: Masafumi Fukagawa; Tadao Akizawa
Calcium abnormalities of dialysis patients.
Journal of bone and mineral metabolism 2006;24(2):160.
2005: Tadao Akizawa; Takashi Akiba; Masaaki Inaba; Takashi Shigematsu; Kevin J Martin
[significance of PTH (1-84) assay in the management of chronic renal failure and the current status and future of the treatment of renal osteopathy].
Clinical calcium 2005;15(11):136-159.
2005: Hikari Orita; Ikuji Hatamura; Fumie Saji; Makie Shibata; Kazuhiro Shiizaki; Toshifumi Sakaguchi; Shigeo Negi; Tadao Akizawa
[Enhanced expression of EGFR, TGF-alpha, EGF in hyperplastic parathyroid glands in established stage of renal failure in rats].
Clinical calcium 2005;15 Suppl 1():60-63; discussion 63.
2005: Masahide Mizobuchi; Fumie Saji; Kazuhiro Shiizaki; Toshihiro Sato; Maki Shibata; Shigeo Negi; Tadao Akizawa; Ikuji Hatamura; Hiroaki Ogata; Eriko Kinugasa
[Apoptosis: a possible mechanism of suppressing parathyroid hyperplasia by calcimimetics].
Clinical calcium 2005;15 Suppl 1():56-8; discussion 58-9.
2005: Satoshi Morita; Shunichi Fukuhara; Tadao Akizawa; Yasushi Asano; Kiyoshi Kurokawa
Study design and methods for a clinical trial of an oral carbonaceous adsorbent used to prevent the progression of chronic kidney disease (CAP-KD).
Clinical and experimental nephrology 2005;9(3):219-27.
2005: Toshifumi Sakaguchi; Tadao Akizawa
[Overview of dialysis therapy for diabetic nephropathies].
Nihon rinsho. Japanese journal of clinical medicine 2005;63 Suppl 6():469-74.
2005: Masahide Mizobuchi; Tadao Akizawa
[Calcium sensing receptor (CaR) agonist].
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 2005;94(5):979-83.
2005: Naoki Kimata; Takashi Akiba; Ronald L Pisoni; Justin M Albert; Sudtida Satayathum; José Miguel Cruz; Tadao Akizawa; Vittorio E Andreucci; Eric W Young; Friedrich K Port
Mineral metabolism and haemoglobin concentration among haemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(5):927-35.
2005: Eric W Young; Justin M Albert; Sudtida Satayathum; David A Goodkin; Ronald L Pisoni; Takashi Akiba; Tadao Akizawa; Kiyoshi Kurokawa; Jürgen Bommer; Luis Piera; Friedrich K Port
Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study.
Kidney international 2005;67(3):1179-87.
2005: Yukiko Kitabata; Hikari Orita; Motohiro Kamimura; Kazuhiro Shiizaki; Nobuhiko Narukawa; Takaya Abe; Hirotsugu Kobata; Tadao Akizawa
Symptomatic bradycardia probably due to tizanidine hydrochloride in a chronic hemodialysis patient.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2005;9(1):74-7.
2005: Masafumi Fukagawa; Tadao Akizawa
How to apply and adapt international guidelines on bone metabolism and disease to the management of Japanese dialysis patients.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2005;9(1):1-2.
2005: Satoshi Kurihara; Yoshinari Tsuruta; Tadao Akizawa
Effect of MCI-196 (colestilan) as a phosphate binder on hyperphosphataemia in aemodialysis patients: a double-blind, placebo-controlled, short-term trial.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(2):424-30.
2005: Nancy A Mason; George R Bailie; Sudtida Satayathum; Jennifer Bragg-Gresham; Takashi Akiba; Tadao Akizawa; Christian Combe; Hugh C Rayner; Akira Saito; Brenda W Gillespie; Eric W Young
HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;45(1):119-26.
2005: Kazuhiro Shiizaki; Shigeo Negi; Ikuji Hatamura; Toshifumi Sakaguchi; Fumie Saji; Ken Kunimoto; Masahide Mizobuchi; Ikuo Imazeki; Akira Ooshima; Tadao Akizawa
Biochemical and cellular effects of direct maxacalcitol injection into parathyroid gland in uremic rats.
Journal of the American Society of Nephrology : JASN 2005;16(1):97-108.
2004: Tadao Akizawa; Yasuo Ohashi; Takashi Akiba; Masashi Suzuki; Yoshiki Nishizawa; Etsuro Ogata; Eduardo Slatopolsky; Kiyoshi Kurokawa
Dose-response study of 22-oxacalcitriol in patients with secondary hyperparathyroidism.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2004;8(6):480-91.
2004: Fumitake Gejyo; Akira Saito; Tadao Akizawa; Takashi Akiba; Tatsuya Sakai; Masashi Suzuki; Shinichi Nishi; Yoshiharu Tsubakihara; Hideki Hirakata; Masami Bessho
2004 Japanese Society for Dialysis Therapy guidelines for renal anemia in chronic hemodialysis patients.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2004;8(6):443-59.
2004: Motohiro Kamimura; Florian Bea; Tadao Akizawa; Hugo A Katus; Jörg Kreuzer; Christiane Viedt
Platelet-derived growth factor induces tissue factor expression in vascular smooth muscle cells via activation of Egr-1.
Hypertension 2004;44(6):944-51.
2004: Francesco Locatelli; Ronald L Pisoni; Tadao Akizawa; José Miguel Cruz; Peter B Deoreo; Norbert H Lameire; Philip J Held
Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns Study (DOPPS) findings.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;44(5 Suppl 2):27-33.
2004: Masahide Mizobuchi; Ikuji Hatamura; Hiroaki Ogata; Fumie Saji; Susumu Uda; Kazuhiro Shiizaki; Toshifumi Sakaguchi; Shigeo Negi; Eriko Kinugasa; Shozo Koshikawa; Tadao Akizawa
Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency.
Journal of the American Society of Nephrology : JASN 2004;15(10):2579-87.
2004: Tadao Akizawa; Shigeo Negi
[Renal osteodystrophy].
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 2004;93(9):1924-9.
2004: Toshifumi Sakaguchi; Tadao Akizawa
[K/DOQI clinical practice guidelines for bone metabolism and disease in CKD].
Clinical calcium 2004;14(9):9-14.
2004: Rajiv Saran; Dawn M Dykstra; Ronald L Pisoni; Takashi Akiba; Tadao Akizawa; Bernard Canaud; Kenneth Chen; Luis Piera; Akira Saito; Eric W Young
Timing of first cannulation and vascular access failure in haemodialysis: an analysis of practice patterns at dialysis facilities in the DOPPS.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(9):2334-40.
2004: Ronald L Pisoni; Jennifer Bragg-Gresham; Eric W Young; Tadao Akizawa; Yasushi Asano; Francesco Locatelli; Jürgen Bommer; José Miguel Cruz; Peter G Kerr; David C Mendelssohn; Philip J Held; Friedrich K Port
Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;44(1):94-111.
2004: Satoshi Kurihara; Toshio Shinoda; Tadao Akizawa; Chikao Yamazaki; Yoshihei Hhrasawa
[Risk management based on results of nationwide questionaire on medical accidents].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 6():483-7.
2004: Tsutomu Sanaka; Tadao Akizawa; Keizo Koide; Shozo Koshikawa
Protective effect of an oral adsorbent on renal function in chronic renal failure: determinants of its efficacy in diabetic nephropathy.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2004;8(3):232-40.
2004: Takaya Abe; Mineo Shono; Toshihiro Kodama; Yuji Kita; Masafumi Fukagawa; Tadao Akizawa
Extracorporeal albumin dialysis.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2004;8(3):217-22.
2004: Naro Ohashi; Toshihiko Uematsu; Satoru Nagashima; Mitsutaka Kanamaru; Akashi Togawa; Akira Hishida; Eiji Uchida; Tadao Akizawa; Shozo Koshikawa
The calcimimetic agent KRN 1493 lowers plasma parathyroid hormone and ionized calcium concentrations in patients with chronic renal failure on haemodialysis both on the day of haemodialysis and on the day without haemodialysis.
British journal of clinical pharmacology 2004;57(6):726-34.
2004: Hikari Orita; Tadao Akizawa
[Outlines of K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease].
Clinical calcium 2004;14(5):693-7.
2004: Toshifumi Sakaguchi; Tadao Akizawa
[New preparations of erythropoietin].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 5():360-3.
2004: Shigeo Negi; Tadao Akizawa
[Hemoperfusion].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 5():343-6.
2004: Kazusei Uematsu; Tadao Akizawa
[Biocompatibility].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 5():37-40.
2004: Kazuhiro Shiizaki; Shinji Sumikado; Tadao Akizawa
[Low PTH level and adynamic bone disease in dialysis patients].
Clinical calcium 2004;14(1):16-20.
2003: Shunichi Fukuhara; Antonio Alberto Lopes; Jennifer Bragg-Gresham; Kiyoshi Kurokawa; Donna L Mapes; Tadao Akizawa; Jürgen Bommer; Bernard Canaud; Friedrich K Port; Philip J Held
Health-related quality of life among dialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study.
Kidney international 2003;64(5):1903-10.
2003: Tadao Akizawa; Motohiro Kamimura; Masahide Mizobuchi; Kazuhiro Shiizaki; Shinji Sumikado; Toshifumi Sakaguchi; Shigeo Negi; Hiroaki Ogata; Eriko Kinugasa
Management of secondary hyperparathyroidism of dialysis patients.
Nephrology (Carlton, Vic.) 2003;8 Suppl():S53-7.
2003: Takaya Abe; Kazuhiro Uchita; Hikari Orita; Motohiro Kamimura; Minoru Oda; Hirohito Hasegawa; Hirotsugu Kobata; Masaaki Fukunishi; Masami Shimazaki; Tomiya Abe; Tadao Akizawa; Suhail Ahmad
Effect of beta(2)-microglobulin adsorption column on dialysis-related amyloidosis.
Kidney international 2003;64(4):1522-8.
2003: Kazuhiro Shiizaki; Ikuji Hatamura; Shigeo Negi; Nobuhiko Narukawa; Masahide Mizobuchi; Toshifumi Sakaguchi; Akira Ooshima; Tadao Akizawa
Percutaneous maxacalcitol injection therapy regresses hyperplasia of parathyroid and induces apoptosis in uremia.
Kidney international 2003;64(3):992-1003.
2003: Kazuo Ota; Tadao Akizawa; Yoshihei Hirasawa; Tetsuzo Agishi; Noriaki Matsui
Effects of argatroban as an anticoagulant for haemodialysis in patients with antithrombin III deficiency.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18(8):1623-30.
2003: Kazuhiro Shiizaki; Shigeo Negi; Masahide Mizobuchi; Ikuji Hatamura; Nobuhiko Narukawa; Toshifumi Sakaguchi; Yukiko Kitabata; Shinji Sumikado; Tadao Akizawa
Effect of percutaneous calcitriol injection therapy on secondary hyperparathyroidism in uraemic patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18 Suppl 3():iii42-6.
2003: Masafumi Fukagawa; Masafumi Kitaoka; Yoshihiro Tominaga; Tadao Akizawa; Takatoshi Kakuta; Noritaka Onoda; Fumihiko Koiwa; Shigeru Yumita; Kiyoshi Kurokawa
Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18 Suppl 3():iii31-3.
2003: Tsutomu Sanaka; Tadao Akizawa; Keizo Koide; Shozo Koshikawa
Clinical analysis of renoprotective responding patients administrated with oral adsorbent in chronic renal failure secondary to chronic glomerulonephritis.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2003;7(2):269-78.
2003: Akio Kaketaka; Tadao Akizawa
[Renal osteodystrophy and vitamin D].
Clinical calcium 2003;13(3):285-9.
2003: Tadao Akizawa; Kazuhiro Shiizaki; Ikuji Hatamura; Motohiro Kamimura; Masahide Mizobuchi; Nobuhiko Narukawa; Shinji Sumikado; Toshifumi Sakaguchi; Shigeo Negi; Hiroaki Ogata; Eriko Kinugasa
New strategies for the treatment of secondary hyperparathyroidism.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;41(3 Suppl 1):S100-3.
2003: Tsutomu Sanaka; Kumiko Fujimoto; Jun Niwayama; Hideki Nishimura; Takashi Naito; Chieko Higuchi; Tadao Akizawa; Keizo Koide; Shozo Koshikawa
Effect of combined treatment of oral sorbent with protein-restricted diet on change of reciprocal creatinine slope in patients with CRF.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;41(3 Suppl 1):S35-7.
2003: Shozo Koshikawa; Tadao Akizawa; Akira Saito; Kiyoshi Kurokawa
Clinical effect of short daily in-center hemodialysis.
Nephron. Clinical practice 2003;95(1):c23-30.
2003: Hugh C Rayner; Ronald L Pisoni; Brenda W Gillespie; David A Goodkin; Takashi Akiba; Tadao Akizawa; Akira Saito; Eric W Young; Friedrich K Port
Creation, cannulation and survival of arteriovenous fistulae: data from the Dialysis Outcomes and Practice Patterns Study.
Kidney international 2003;63(1):323-30.
2002: Hikari Orita; Tadao Akizawa
[The new trend on the treatment of secondary hyperparathyroidism].
Clinical calcium 2002;12(12):1631-5.
2002: Motohiro Kamimura; Masaki Matsuo; Takashi Miyahara; Karue Kimura; Kimiyo Matsumoto; Tsuyoshi Nakaya; Tomiya Abe; Tadao Akizawa
Improvements in artery occlusion by low-density lipoprotein apheresis in a patient with peripheral arterial disease.
Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis 2002;6(6):467-70.
2002: Nobutoshi Iida; Syozo Koshikawa; Tadao Akizawa; Yoshiharu Tsubakihara; Fumiaki Marumo; Takashi Akiba; Yoshindo Kawaguchi; Akio Imada; Chikao Yamazaki; Masashi Suzuki
Effects of L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in hemodialysis patients.
American journal of nephrology 2002;22(4):338-46.
2002: Tadao Akizawa; Kiyoshi Kurokawa
[Long-term clinical effect of maxacalcitol on hemodialysis patients with secondary hyperparathyroidism].
Clinical calcium 2002;12(6):781-8.
2002: Yoshiharu Yamada; Tadao Akizawa; Kiyoshi Kurokawa
[Clinical development of OCT].
Clinical calcium 2002;12(6):749-53.
2002: Toshifumi Sakaguchi; Tadao Akizawa
[Clinical guideline review: Standards for initiation of chronic dialysis].
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 2002;91(5):1561-9.
2002: Tadao Akizawa; Shozo Koshikawa; Nobutoshi Iida; Fumiaki Marumo; Takashi Akiba; Yoshindo Kawaguchi; Akio Imada; Chikao Yamazaki; Masashi Suzuki; Yoshiharu Tubakihara
Clinical effects of L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in hemodialysis patients.
Nephron 2002;90(4):384-90.
2002: Akira Matsuda; Masami Bessho; Shigehisa Mori; Tsutomu Takeuchi; Tohru Abe; Yoshihito Yawata; Hiraku Mori; Mitsuhiro Omine; Yuichi Nakamura; Shinpei Furusawa; Teiryo Maeda; Susumu Haginosita; Yoshihei Hirasawa; Eriko Kinugasa; Tadao Akizawa; Naohito Kawakami; Atsuo Nagata; Kunitake Hirashima
Diagnostic significance of serum soluble transferrin receptors in various anemic diseases: the first multi-institutional joint study in Japan.
Haematologia 2002;32(3):225-38.
2002: Tadao Akizawa; Masashi Suzuki; Takashi Akiba; Yoshiki Nishizawa; Yasuo Ohashi; Etsuro Ogata; Eduardo Slatopolsky; Kiyoshi Kurokawa
Long-term effect of 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in haemodialysis patients. One-year administration study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17 Suppl 10():28-36.
2002: Eriko Kinugasa; Tadao Akizawa; Junko Takahashi; Kunihiro Nabeshima; Hiroaki Ogata; Fumiyoshi Nakayama; Terukuni Ideura
Effects of 1,25-dihydroxy-22-oxavitamin D(3) on parathyroid gland function in haemodialysis patients with secondary hyperparathyroidism.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17 Suppl 10():20-7.
2001: Nobuhiko Narukawa; Kazuhiro Shiizaki; Yukiko Kitabata; Tomiya Abe; Hirotsugu Kobata; Tadao Akizawa
Plasma exchange for the treatment of human T-cell lymphotropic virus type 1 associated myelopathy.
Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis 2001;5(6):491-3.
2001: Yukiko Kitabata; M Sakurane; Hikari Orita; Motohiro Kamimura; K Siizaki; Nobuhiko Narukawa; A Kaketaka; Tomiya Abe; Hirotsugu Kobata; Tadao Akizawa
Double filtration plasmapheresis for the treatment of bullous pemphigoid: a three case report.
Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis 2001;5(6):484-90.
2001: M Kamimura; Tadao Akizawa
[Hyperphosphatemia and hypoparathyroidism].
Clinical calcium 2001;11(10):1330-4.
2001: Tadao Akizawa; M Suzuki; T Akiba; Y Nishizawa; K Kurokawa
Clinical effects of maxacalcitol on secondary hyperparathyroidism of uremic patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;38(4 Suppl 1):S147-51.
2001: Yukiko Kitabata; Tadao Akizawa
[Effect of concomitant therapy on adynamic bone disease].
Clinical calcium 2001;11(8):1048-52.
2001: Tomiya Abe; T Abe; S Ageta; T Kakuta; N Suzuki; H Hirata; M Shouno; H Saio; Tadao Akizawa
A new method for removal of albumin-binding uremic toxins: efficacy of an albumin-dialysate.
Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis 2001;5(1):58-63.
2001: M Okamoto; Tomiya Abe; M Shouno; Yukiko Kitabata; Nobuhiko Narukawa; Hirotsugu Kobata; Tadao Akizawa
A case of thrombotic thrombocytopenic purpura refractory to plasma exchange.
Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis 2001;5(1):49-53.
2000: Masafumi Fukagawa; Tadao Akizawa; Kiyoshi Kurokawa
Is aplastic osteodystrophy a disease of malnutrition?
Current opinion in nephrology and hypertension 2000;9(4):363-7.
2000: Tadao Akizawa; Nobuhiko Narukawa
[Syndrome related to chronic dialysis].
Ryōikibetsu shōkōgun shirīzu 2000;(29 Pt 4):147-9.
2000: T Abe; Tadao Akizawa
[Dialysis dysequilibrium syndrome(DDS)].
Ryōikibetsu shōkōgun shirīzu 2000;(29 Pt 4):143-5.
2000: Eriko Kinugasa; Terukuni Ideura; Tadao Akizawa
[Dialysis encephalopathy, dialysis dementia].
Ryōikibetsu shōkōgun shirīzu 2000;(29 Pt 4):139-42.
1999: Nobuhiko Narukawa; Tomiya Abe; M Shouno; Yukiko Kitabata; M Okamoto; Hirotsugu Kobata; Tadao Akizawa
A case of factor VIII inhibitor-positive acquired hemophilia treated by plasmapheresis.
Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis 1999;3(4):323-5.
1999: H Ogata; S Sakai; Fumihiko Koiwa; Hironori Tayama; Eriko Kinugasa; Terukuni Ideura; Tadao Akizawa
Plasma exchange for acquired hemophilia: a case report.
Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis 1999;3(4):320-2.
1999: A Satomi; S Nagai; T Nagai; K Niikura; Terukuni Ideura; H Ogata; Tadao Akizawa
Effect of plasma exchange on refractory hemophagocytic syndrome complicated with myelodysplastic syndrome.
Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis 1999;3(4):317-9.
1999: K Takahashi; Fumihiko Koiwa; Hironori Tayama; A Satomi; Tadao Akizawa; Terukuni Ideura
A case of acute spontaneous epidural haematoma in a chronic renal failure patient undergoing haemodialysis: successful outcome with surgical management.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(10):2499-501.
1999: Tadao Akizawa; Hajime Suzuki
[Adenoviral pneumonia].
Ryōikibetsu shōkōgun shirīzu 1999;(24 Pt 2):93-5.
1999: Tadao Akizawa; H Ogata; Fumihiko Koiwa; Eriko Kinugasa; Terukuni Ideura
The role of calcium-sensing receptor abnormality in the pathogenesis of secondary hyperparathyroidism.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14 Suppl 1():66-7.
1998: A Satomi; Fumihiko Koiwa; H Ogata; Eriko Kinugasa; Tadao Akizawa; Terukuni Ideura
Plasma exchange for thrombocytopenia in antiphospholipid syndrome: a case report.
Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis 1998;2(2):157-9.
1997: Tadao Akizawa; Eriko Kinugasa; T Akiba; Y Tsukamoto; K Kurokawa
Incidence and clinical characteristics of hypoparathyroidism in dialysis patients.
Kidney international. Supplement 1997;62():S72-4.
1997: Tadao Akizawa; T Nemoto
[Hyperparathyroidism, hypoparathyroidism].
Ryōikibetsu shōkōgun shirīzu 1997;(17 Pt 2):132-6.
1996: T Nagai; Tadao Akizawa; S Kohjiro; Fumihiko Koiwa; K Nabeshima; K Niikura; K Kino; N Kanamori; Eriko Kinugasa; Terukuni Ideura
rHuEPO enhances the production of plasminogen activator inhibitor-1 in cultured endothelial cells.
Kidney international 1996;50(1):102-7.
1996: Tadao Akizawa; Eriko Kinugasa; Fumihiko Koiwa; S Kohjiro; Terukuni Ideura
Dialysis membranes in the year 2000: performance and biocompatibility.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1996;11 Suppl 8():16-9.
1995: Tadao Akizawa; K Shishido; S Koshikawa
The effects and pharmacokinetics of rhG-CSF in patients with chronic renal failure.
Artificial organs 1995;19(12):1251-7.
1995: M Wakasa; Tadao Akizawa; Eriko Kinugasa; S Koshikawa
Plasma bradykinin levels during hemodialysis with PAN DX and polysulfone membranes with and without concurrent ACE inhibitor.
Clinical nephrology 1995;44 Suppl 1():S29-32.
1995: T Nagai; Tadao Akizawa; Y Nakashima; S Kohjiro; K Nabeshima; N Kanamori; K Takayama; Eriko Kinugasa; S Koshikawa
Effects of rHuEpo on cellular proliferation and endothelin-1 production in cultured endothelial cells.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10(10):1814-9.
1995: K Niikura; Tadao Akizawa; Y Satoh; Fumihiko Koiwa; N Kanamori; Eriko Kinugasa; S Koshikawa
Relative hypoparathyroidism in hemodialysis patients.
Mineral and electrolyte metabolism 1995;21(1-3):101-3.
1995: K Kino; Tadao Akizawa; S Koshikawa
Effects of membrane characteristics on cytokine production by mononuclear cells in regular haemodialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10 Suppl 3():29-33.
1994: Tadao Akizawa; Eriko Kinugasa; M Wakasa; S Kohjiro; Fumihiko Koiwa; S Koshikawa
Effect of dialysis membranes and ACE inhibitor on bradykinin levels during hemodialysis.
Clinical nephrology 1994;41(4):241-4.
1994: Tadao Akizawa; H Suzuki
[Herpesvirus pneumonia].
Ryōikibetsu shōkōgun shirīzu 1994;(3):110-2.
1994: Tadao Akizawa; Eriko Kinugasa; S Koshikawa
Increased risk of malignancy and blood-membrane interactions in uraemic patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1994;9 Suppl 2():162-4.
1993: Y Nakashima; Tadao Akizawa; T Nagai; S Koshikawa
Role of uremic and endothelial factors in the development of beta 2-microglobulin amyloidosis.
Kidney international. Supplement 1993;41():S88-95.
1993: Tadao Akizawa; S Koshikawa; K Ota; M Kazama; N Mimura; Y Hirasawa
Nafamostat mesilate: a regional anticoagulant for hemodialysis in patients at high risk for bleeding.
Nephron 1993;64(3):376-81.
1992: Eriko Kinugasa; Tadao Akizawa; Y Nakashima; M Wakasa; S Koshikawa
Nafamostat as anti-coagulant for membrane plasmapheresis in high bleeding risk patients.
The International journal of artificial organs 1992;15(10):595-600.
1992: Y Nakazima; Tadao Akizawa; S Koshikawa
[Dialysis-related amyloidosis].
Nihon rinsho. Japanese journal of clinical medicine 1992;50 Suppl():807-16.
1992: Eriko Kinugasa; T Makita; Tadao Akizawa; S Koshikawa
[Treatment of uremic patients at high bleeding risk].
Nihon rinsho. Japanese journal of clinical medicine 1992;50 Suppl():118-24.
1991: Tadao Akizawa; K Nabeshima; S Kawabe
[Biocompatibility of synthetic membrane for blood purification therapy].
Nihon rinsho. Japanese journal of clinical medicine 1991;49 Suppl():53-60.
1991: K Shishido; K Niikura; Tadao Akizawa; S Koshikawa
[The effects and pharmacokinetics of rhG-CSF on the treatment of neutropenia in patients with renal failure].
Nihon Jinzo Gakkai shi 1991;33(10):973-81.
1991: K Takayama; T Nagai; Eriko Kinugasa; Tadao Akizawa; S Koshikawa
Changes in endothelial vasoactive substances under recombinant human erythropoietin therapy in hemodialysis patients.
ASAIO transactions / American Society for Artificial Internal Organs 1991;37(3):M187-8.
1991: Tadao Akizawa; Eriko Kinugasa; S Koshikawa
Endothelin and platelet activating factor. Possible indices for biocompatibility of hemodialysis.
ASAIO transactions / American Society for Artificial Internal Organs 1991;37(3):M384-5.
1991: Tadao Akizawa; Eriko Kinugasa; T Kitaoka; S Koshikawa
Effects of recombinant human erythropoietin and correction of anemia on platelet function in hemodialysis patients.
Nephron 1991;58(4):400-6.
1990: T Nagai; Tadao Akizawa; T Kitaoka; S Koshikawa
[Acid-base imbalance in diabetic mellitus].
Nihon rinsho. Japanese journal of clinical medicine 1990;48 Suppl():714-21.
1990: Eriko Kinugasa; K Nabeshima; K Niikura; S Kawabe; Tadao Akizawa; T Kitaoka; S Koshikawa
[The effects of r-HuEPO on platelet function and coagulation factors in hemodialysis patients].
Nihon Jinzo Gakkai shi 1990;32(10):1109-16.
1990: Tadao Akizawa
[Beneficial characteristics of protease inhibitor as an anticoagulant for extracorporeal circulation].
[Rinshō ketsueki] The Japanese journal of clinical hematology 1990;31(6):782-6.
1989: Tadao Akizawa; S Koshikawa; R Nakazawa; T Yoshida; M Kaneko; Y Nitadori
Elimination of beta 2-microglobulin by a new polyacrylonitrile membrane dialyser: mechanism and physiokinetics.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1989;4(5):356-65.
1988: Tadao Akizawa; S Koshikawa; F Takaku; A Urabe; N Akiyama; N Mimura; Osamu Otsubo; H Nihei; Y Suzuki; Y Kawaguchi
Clinical effect of recombinant human erythropoietin on anemia associated with chronic renal failure. A multi-institutional study in Japan.
The International journal of artificial organs 1988;11(5):343-50.
1988: Eriko Kinugasa; Tadao Akizawa; T Kitaoka; S Koshikawa
Evaluation of beta 2-microglobulin removal with high-performance hemodiafiltration.
Artificial organs 1988;12(1):11-5.
1987: Tadao Akizawa; Eriko Kinugasa; T Kitaoka; S Koshikawa; N Nakabayashi; H Watanabe; N Yamawaki; Y Kuroda
Removal of beta-2-microglobulin by direct hemoperfusion with a newly developed adsorbent.
ASAIO transactions / American Society for Artificial Internal Organs 1987;33(3):532-7.